In vitro teratogenicity of ethylenethiourea in the rat. 1987

G P Daston, and M T Ebron, and B Carver, and J G Stefanadis

We have demonstrated that ethylenethiourea (ETU) is a potent teratogen to the rat embryo developing in vitro. Sprague Dawley rat embryos were explanted on gestation day 10 and cultured for 48 hours in the presence of 40-200 micrograms/ml ETU. This resulted in a dose-related inhibition of growth and differentiation as assessed by crown-rump length, protein and DNA content, and somite number and in an increase in the frequency of abnormalities. A variety of anomalies was produced, including fluid accumulation in the brain (hydrocephalus), decreased mandibular size, decreased telencephalon size, abnormal dorsiflexion, as well as subectodermal blisters on the tail and limb buds and maxilla. Frank malformations have been observed at these same sites--hydrocephalus, brachygnathia, kyphosis, limb and tail defects, cleft palate--in the term fetus in vivo. The presence of abnormal fluid accumulation in the embryos--distended neural tube and subectodermal blisters--suggesting that the osmotic environment of the embryo had been altered by ETU exposure. Osmolality of the exocoelomic fluid (ECF) surrounding the embryo was measured after 48 hours of exposure to a concentration of ETU that caused nearly a 100% incidence of subectodermal blisters. ECF osmolality was found to be significantly lower than that of control embryos. Lowered osmolality would cause water to move out of the ECF, presumably causing the observed fluid accumulation in the embryo. It is speculated that altered osmotic balance and localized edema in the embryo are contributory steps in the formation of defects after ETU exposure.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004477 Ectogenesis Embryonic and fetal development that takes place in an artificial environment in vitro. Ectogeneses
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005031 Ethylenethiourea A degradation product of ethylenebis(dithiocarbamate) fungicides. It has been found to be carcinogenic and to cause THYROID hyperplasia. Imidazolidinethione,2-Mercaptoimidazoline,Imidazolidine-2-thione,2 Mercaptoimidazoline
D005110 Extracellular Space Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the extracellular space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall. Intercellular Space,Extracellular Spaces,Intercellular Spaces,Space, Extracellular,Space, Intercellular,Spaces, Extracellular,Spaces, Intercellular
D005260 Female Females
D000014 Abnormalities, Drug-Induced Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. Drug-Induced Abnormalities,Abnormalities, Drug Induced,Abnormality, Drug-Induced,Drug Induced Abnormalities,Drug-Induced Abnormality
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013723 Teratogens An agent that causes the production of physical defects in the developing embryo. Embryotoxins,Fetotoxins,Teratogen

Related Publications

G P Daston, and M T Ebron, and B Carver, and J G Stefanadis
April 1990, Teratology,
G P Daston, and M T Ebron, and B Carver, and J G Stefanadis
April 1978, Teratology,
G P Daston, and M T Ebron, and B Carver, and J G Stefanadis
June 1973, Teratology,
G P Daston, and M T Ebron, and B Carver, and J G Stefanadis
June 1982, Teratology,
G P Daston, and M T Ebron, and B Carver, and J G Stefanadis
October 1982, Teratology,
G P Daston, and M T Ebron, and B Carver, and J G Stefanadis
January 1980, Toxicology and applied pharmacology,
G P Daston, and M T Ebron, and B Carver, and J G Stefanadis
February 1983, Teratology,
G P Daston, and M T Ebron, and B Carver, and J G Stefanadis
January 1987, Critical reviews in toxicology,
G P Daston, and M T Ebron, and B Carver, and J G Stefanadis
February 1984, Toxicology and applied pharmacology,
G P Daston, and M T Ebron, and B Carver, and J G Stefanadis
January 1987, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement,
Copied contents to your clipboard!